Mark Warren

Mark Warren is the current Director of Preclinical Business Development at QPS. Mark has over 20 years of experience in the field of bioanalytical sciences.

Warren began their career as a Research Chemist at Charles River Laboratories, where they worked for two years before moving to McGill University, where they worked as a Research Associate and Faculty Lecturer for six years.

In 2006, Warren began working in the pharmaceutical industry, first as a Quality Control Chemist at Molson Coors Canada for two years, then as a Project Director at PRA Health Sciences for three years. Mark then spent a year as Laboratory Director at Lambda Therapeutic Research before moving to Atlanbio, where they spent four years as Senior Director of Bioanalytical Sciences.

In 2013, Warren returned to the pharmaceutical industry, this time as Senior Director of Bioanalytical Sciences at Charles River Laboratories. Mark held this position for a year before moving to their current role at QPS in 2015.

Mark Warren has a BSc from Memorial University of Newfoundland in Biochemistry and a degree from McGill University in Nutritional Biochemistry and Metabolism.

The team of Mark Warren, Director, Preclinical Business Development, is responsible for the business development of preclinical products and services. The team includes Lillian Rosa, Inigo Montes, Dawn Moore, Camille Picq, and John Katiforis.